Top Buy
| Security | Buy | Sell ▲ | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Insmed Inc. | 13 | 1 | 3 | 1 | €23.00 | €44.01 | 91.333% |
| Dr. Reddy's Laboratories Ltd. ADR | 5 | 1 | 1 | 0 | €69.00 | €73.92 | 7.130% |
| Zoetis Inc. A | 20 | 1 | 3 | 1 | €148.46 | €201.64 | 35.818% |
| AbbVie Inc. | 18 | 1 | 1 | 1 | €149.14 | €175.79 | 17.868% |
| Natural Alternat. | 18 | 1 | 1 | 0 | €5.65 | - | - |
| Bayer AG | 15 | 1 | 0 | 0 | €27.45 | €50.00 | 82.183% |
| Stoke Therapeutics Inc | 14 | 1 | 2 | 0 | €11.40 | €21.00 | 84.242% |
| EyePoint Pharmaceuticals Inc. | 14 | 1 | 0 | 1 | €15.63 | €28.17 | 80.216% |
| Adverum Biotechnologies Inc. | 4 | 1 | 0 | 0 | €1.38 | €3.70 | 168.304% |
| Adaptimmune Therapeutics PLC ADR | 1 | 1 | 0 | 1 | €1.00 | €1.50 | 50.000% |
| Xencor Inc. | 9 | 1 | 1 | 0 | €18.70 | €31.74 | 69.727% |
| Regeneron Pharmaceuticals Inc. | 33 | 1 | 6 | 1 | €822.00 | €957.22 | 16.450% |
| Nektar Therapeutics | 3 | 1 | 1 | 0 | €1.26 | €3.70 | 194.821% |
| G1 Therapeutics | 13 | 1 | 1 | 0 | €3.60 | €10.05 | 178.968% |
| Merck & Co. Inc. | 28 | 1 | 3 | 0 | €122.20 | €124.93 | 2.233% |
| Heron Therapeutics Inc. | 9 | 1 | 3 | 0 | €2.29 | €4.57 | 99.381% |
| Ultragenyx Pharmaceutical Inc. | 16 | 1 | 3 | 0 | €41.40 | €82.93 | 100.317% |
| Novo Nordisk A/S ADR | 17 | 1 | 3 | 0 | €119.00 | €130.44 | 9.612% |
| Chromadex Corp | 10 | 2 | 1 | 0 | €3.22 | €5.76 | 78.770% |
| Codexis Inc. | 4 | 2 | 0 | 0 | €2.48 | €8.35 | 236.738% |
| Biogen Inc. | 44 | 2 | 4 | 1 | €194.55 | €294.45 | 51.349% |
| Vertex Pharmaceuticals Inc. | 40 | 2 | 5 | 0 | €370.80 | €382.71 | 3.211% |
| Iovance Biotherapeutics Inc. | 19 | 3 | 0 | 0 | €10.86 | €22.78 | 109.717% |
| Akebia Therapeutics Inc. | 8 | 3 | 1 | 0 | €1.25 | €3.60 | 188.389% |
| Immunic Inc. | 6 | 3 | 1 | 3 | €1.15 | €5.48 | 378.760% |